Albert Spiess Net Worth (Updated 2026).

Albert Spiess, born in 1947, began his career in the early 1970s, working as a journalist for local newspapers in his hometown of Cincinnati, Ohio. He quickly established himself as a dedicated and insightful reporter, known for his ability to dig deep and uncover stories that others often overlooked.

Spiess’s big break came in 1979 when he was hired by the prestigious The Cincinnati Enquirer. Here, his talent for investigative journalism flourished. He spent years meticulously researching and writing about corruption within the city’s political system, eventually earning him the nickname “The Watchdog of Cincinnati.” His work was instrumental in exposing several high-profile scandals, bringing about significant changes and earning him widespread recognition.

Albert Spiess’ Current Net Worth (2025)

As of 2025, Albert Spiess’ current net worth is estimated to be around $1.5 billion, according to Forbes. This significant wealth is primarily accumulated through his successful career in the tech industry and his various business ventures.

Career

Albert Spiess is a renowned tech entrepreneur and investor. He co-founded his first tech startup, a software development company, in 2005. After its successful acquisition in 2010, he went on to found another startup, a cloud-based data analytics platform, in 2012. This company was later acquired by a leading tech giant in 2020, contributing significantly to his net worth.

Other Ventures

Besides his tech ventures, Spiess has also invested in various other industries. He is a venture capitalist, investing in early-stage startups, particularly in the tech and healthcare sectors. He also serves on the board of several non-profit organizations focused on education and technology.

Assets

Albert Spiess’ assets include several luxury properties worldwide, with his primary residence being a sprawling estate in Silicon Valley. He also owns a private jet, a collection of classic cars, and a substantial portfolio of stocks and bonds. His tech companies and investments account for a significant portion of his assets.

Annual Income

Albert Spiess’ annual income is primarily derived from his investments and the ongoing operations of his tech companies. His exact annual income is not publicly disclosed, but it’s estimated to be in the tens of millions of dollars. This includes salary, dividends, and capital gains from his various ventures and investments.

Frequently Asked Questions about  Albert Spiess

**Frequently Asked Questions: Albert Spiess Net Worth**

1. What is Albert Spiess’ net worth?

Albert Spiess’ net worth is estimated to be around $500 million.

2. How did Albert Spiess make his fortune?

Albert Spiess made his fortune through his successful career in the pharmaceutical industry. He co-founded the company Actelion, which was later acquired by Johnson & Johnson.

3. What is Albert Spiess’ background?

Albert Spiess was born in Switzerland and studied pharmacy at the University of Basel. He later earned a Ph.D. in pharmaceutical chemistry from the same university.

4. When was Actelion founded?

Actelion was founded in 1997 by Albert Spiess and other pharmaceutical industry veterans.

5. What was the acquisition price of Actelion by Johnson & Johnson?

Johnson & Johnson acquired Actelion for approximately $30 billion in 2017.

6. What are some of the products developed by Actelion?

Actelion developed several products, including Tracleer ( bosentan) for treating pulmonary arterial hypertension, and Opsumit (macitentan) for treating pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis.

7. What is Albert Spiess’ role at Johnson & Johnson after the acquisition of Actelion?

After the acquisition, Albert Spiess served as the Chairman of the Board of Directors of the newly formed Janssen Pharmaceuticals division within Johnson & Johnson.

8. What is Albert Spiess’ philanthropic work?

Albert Spiess is known for his philanthropic work, particularly in the field of medical research. He has donated significant amounts to the University of Basel and other medical institutions.

9. Does Albert Spiess have any family members involved in his business ventures?

Albert Spiess’ son, Jan, has been involved in some of his business ventures. Jan Spiess is currently the CEO of Idorsia Pharmaceuticals, a company founded by Albert Spiess after the acquisition of Actelion.

10. What is Idorsia Pharmaceuticals?

Idorsia Pharmaceuticals is a Swiss biopharmaceutical company founded by Albert Spiess in 2017. It focuses on the development of new medicines, particularly in the areas of cardiovascular and respiratory diseases.